Elanco Animal Health Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Elanco Animal Health Inc Unternehmen

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Elanco Animal Health Inc Informationen



BörsenkürzelELAN

Name des UnternehmensElanco Animal Health Inc

IPO-datumSep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

Anzahl der mitarbeiter9000

WertpapierartOrdinary Share

GeschäftsjahresendeSep 20

Addresse2500 Innovation Way N

StadtGREENFIELD

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl46140-9163

Telefon18773526261

Websitehttps://www.elanco.com/

BörsenkürzelELAN

IPO-datumSep 20, 2018

CEOMr. Jeffrey N. (Jeff) Simmons

Führungskräfte von Elanco Animal Health Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Dr. Deborah Turner Kochevar, Ph.D.

Independent Director

79.40K

--

Mr. Paul S. Herendeen

Independent Director

74.50K

--

Mr. James Meer

Senior Vice President, Chief Accounting Officer

62.55K

-1.82%

Ms. Shiv O'Neill

Executive Vice President, General Counsel, Corporate Secretary

53.92K

+100.82%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

2.36M

+36.70%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

205.68K

+7.83%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

150.03K

+26.80%

Mr. Michael J. Harrington

Independent Director

99.26K

--

Mr. Art A. Garcia, CPA

Independent Director

80.96K

--

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Corporate Strategy and Market Development

80.40K

-22.66%

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Pet Health

643.00M

51.81%

Farm Animal

583.00M

46.98%

Contract Manufacturing

15.00M

1.21%

Nach RegionUSD

Name

Umsatz

Anteil

International

648.00M

52.22%

United States

593.00M

47.78%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Pet Health

643.00M

51.81%

Farm Animal

583.00M

46.98%

Contract Manufacturing

15.00M

1.21%

Aktionärsstatistik

Aktualisiert: Sat, Aug 16

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Dodge & Cox

16.69%

PRIMECAP Management Company

10.42%

Fidelity Management & Research Company LLC

9.71%

The Vanguard Group, Inc.

9.59%

Dimensional Fund Advisors, L.P.

4.58%

Andere

49.02%

Aktionäre

Anteil

Dodge & Cox

16.69%

PRIMECAP Management Company

10.42%

Fidelity Management & Research Company LLC

9.71%

The Vanguard Group, Inc.

9.59%

Dimensional Fund Advisors, L.P.

4.58%

Andere

49.02%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

64.88%

Investment Advisor/Hedge Fund

33.32%

Hedge Fund

7.73%

Research Firm

1.86%

Individual Investor

1.11%

Pension Fund

0.98%

Bank and Trust

0.53%

Sovereign Wealth Fund

0.18%

Family Office

0.12%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

856

545.76M

109.85%

-16.85M

2025Q2

882

515.44M

103.78%

-40.64M

2025Q1

974

511.32M

102.96%

-71.50M

2024Q4

996

503.77M

101.85%

-80.73M

2024Q3

1000

494.48M

100.04%

-96.31M

2024Q2

1034

494.94M

100.16%

-92.98M

2024Q1

1051

494.01M

100.22%

-99.13M

2023Q4

1048

492.96M

100.04%

-103.67M

2023Q3

1055

493.54M

100.18%

-93.98M

2023Q2

1067

490.17M

99.54%

-75.35M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Dodge & Cox

82.90M

16.69%

-25.35K

-0.03%

Jun 30, 2025

PRIMECAP Management Company

51.77M

10.42%

+1.54M

+3.07%

Jun 30, 2025

Fidelity Management & Research Company LLC

48.24M

9.71%

+9.93M

+25.93%

Jun 30, 2025

The Vanguard Group, Inc.

47.65M

9.59%

-496.16K

-1.03%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

22.75M

4.58%

+2.28M

+11.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

19.58M

3.94%

-484.75K

-2.42%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

19.55M

3.94%

+3.57M

+22.35%

Jun 30, 2025

Black Creek Investment Management, Inc.

19.25M

3.87%

-2.79M

-12.67%

Jun 30, 2025

Fidelity Institutional Asset Management

16.64M

3.35%

+1.09M

+7.01%

Jun 30, 2025

Citadel Advisors LLC

13.70M

2.76%

+6.83M

+99.53%

Jun 30, 2025

Verbundene ETFs



Aktualisiert: Sun, Nov 2

Name

Anteil

iShares U.S. Pharmaceuticals ETF

3.69%

First Trust Health Care Alphadex Fund

2.98%

Brandes US Small-Mid Cap Value ETF

2.88%

SPDR S&P Pharmaceuticals ETF

2.64%

VanEck Agribusiness ETF

2.01%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.98%

Invesco S&P MidCap 400 Pure Value ETF

1.14%

First Trust NASDAQ Pharmaceuticals ETF

1.14%

Pacer US Export Leaders ETF

1.1%

Federated Hermes MDT Large Cap Value ETF

1.05%

iShares U.S. Pharmaceuticals ETF

Anteil3.69%

First Trust Health Care Alphadex Fund

Anteil2.98%

Brandes US Small-Mid Cap Value ETF

Anteil2.88%

SPDR S&P Pharmaceuticals ETF

Anteil2.64%

VanEck Agribusiness ETF

Anteil2.01%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

Anteil1.98%

Invesco S&P MidCap 400 Pure Value ETF

Anteil1.14%

First Trust NASDAQ Pharmaceuticals ETF

Anteil1.14%

Pacer US Export Leaders ETF

Anteil1.1%

Federated Hermes MDT Large Cap Value ETF

Anteil1.05%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten